Scarica l'app Stockscreener
255.38
3.20%
7.92
Dopo l'orario di chiusura:
257.80
2.42
+0.95%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ILMN Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$247.46
Aprire:
$248.79
Volume 24 ore:
2.30M
Relative Volume:
0.93
Capitalizzazione di mercato:
$38.56B
Reddito:
$4.39B
Utile/perdita netta:
$853.00M
Rapporto P/E:
46.35
EPS:
5.5097
Flusso di cassa netto:
$556.00M
1 W Prestazione:
+11.55%
1M Prestazione:
+16.40%
6M Prestazione:
+106.30%
1 anno Prestazione:
+157.00%
Intervallo 1D:
$247.00
$256.17
Intervallo di 1 settimana:
$232.99
$256.17
Portata 52W:
$88.00
$256.17
Illumina Inc Stock (ILMN) Company Profile
Nome
Illumina Inc
Settore
Industria
Telefono
(858) 202-4500
Indirizzo
5200 ILLUMINA WAY, SAN DIEGO, CA
Compare ILMN vs TMO, DHR, NTRA, A, IQV
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ILMN
Illumina Inc
|
255.38 | 37.37B | 4.39B | 853.00M | 556.00M | 5.5097 |
TMO
Thermo Fisher Scientific Inc
|
665.30 | 243.49B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
221.56 | 155.42B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
390.79 | 56.35B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
165.32 | 47.16B | 7.23B | 1.41B | 1.09B | 4.979 |
IQV
Iqvia Holdings Inc
|
267.86 | 44.46B | 16.63B | 1.39B | 2.12B | 8.0674 |
Illumina Inc Stock (ILMN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-12 | Downgrade | Daiwa Securities | Outperform → Neutral |
| 2025-07-11 | Downgrade | Scotiabank | Sector Outperform → Sector Perform |
| 2025-03-04 | Reiterato | Citigroup | Neutral |
| 2025-02-28 | Downgrade | HSBC Securities | Buy → Hold |
| 2025-02-10 | Downgrade | Barclays | Equal Weight → Underweight |
| 2025-02-07 | Downgrade | TD Cowen | Buy → Hold |
| 2024-12-11 | Downgrade | Citigroup | Buy → Neutral |
| 2024-11-12 | Ripresa | Morgan Stanley | Equal-Weight |
| 2024-10-17 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2024-08-28 | Aggiornamento | Argus | Hold → Buy |
| 2024-08-16 | Aggiornamento | Daiwa Securities | Neutral → Buy |
| 2024-08-14 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2024-08-14 | Aggiornamento | TD Cowen | Hold → Buy |
| 2024-07-10 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-06-03 | Ripresa | Jefferies | Hold |
| 2024-01-16 | Downgrade | HSBC Securities | Buy → Hold |
| 2024-01-04 | Downgrade | TD Cowen | Outperform → Market Perform |
| 2023-12-18 | Aggiornamento | Scotiabank | Sector Perform → Sector Outperform |
| 2023-12-15 | Aggiornamento | Bernstein | Underperform → Mkt Perform |
| 2023-12-14 | Iniziato | Guggenheim | Buy |
| 2023-12-14 | Iniziato | Stephens | Overweight |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2023-12-12 | Downgrade | BofA Securities | Neutral → Underperform |
| 2023-12-11 | Aggiornamento | Citigroup | Sell → Neutral |
| 2023-11-10 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2023-09-28 | Iniziato | Bernstein | Underperform |
| 2023-07-05 | Ripresa | JP Morgan | Neutral |
| 2023-01-25 | Downgrade | Argus | Buy → Hold |
| 2023-01-05 | Iniziato | Scotiabank | Sector Perform |
| 2022-12-12 | Downgrade | Citigroup | Neutral → Sell |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-10-04 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2022-09-28 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2022-08-25 | Iniziato | Credit Suisse | Neutral |
| 2022-07-13 | Downgrade | Barclays | Equal Weight → Underweight |
| 2022-01-18 | Aggiornamento | Stifel | Hold → Buy |
| 2022-01-11 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2022-01-07 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2022-01-06 | Ripresa | Morgan Stanley | Equal-Weight |
| 2022-01-06 | Ripresa | Piper Sandler | Overweight |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-08-19 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2021-06-01 | Aggiornamento | Evercore ISI | Underperform → In-line |
| 2021-03-31 | Downgrade | Atlantic Equities | Overweight → Neutral |
| 2021-03-31 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2021-03-03 | Iniziato | Barclays | Underweight |
| 2020-12-22 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2020-12-17 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2020-10-13 | Downgrade | Guggenheim | Buy → Neutral |
| 2020-09-30 | Iniziato | Atlantic Equities | Overweight |
| 2020-09-29 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2020-09-22 | Downgrade | Stifel | Buy → Hold |
| 2020-09-22 | Downgrade | UBS | Buy → Neutral |
| 2020-09-21 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2020-09-21 | Downgrade | JP Morgan | Overweight → Neutral |
| 2020-09-09 | Iniziato | Morgan Stanley | Equal-Weight |
| 2020-08-07 | Downgrade | Evercore ISI | In-line → Underperform |
| 2020-08-07 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2020-07-07 | Downgrade | Guggenheim | Buy → Neutral |
| 2020-04-24 | Downgrade | Citigroup | Buy → Neutral |
| 2020-04-21 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2020-01-08 | Iniziato | Wells Fargo | Underweight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2020-01-02 | Downgrade | Evercore ISI | Outperform → In-line |
| 2019-11-15 | Iniziato | Stifel | Buy |
| 2019-10-25 | Iniziato | Guggenheim | Buy |
Mostra tutto
Illumina Inc Borsa (ILMN) Ultime notizie
Illumina stock gains 3.62 percent as earnings beat estimates - AD HOC NEWS
Will Index Reshuffle Change Illumina (ILMN) Narrative - simplywall.st
Illumina Inc. stock outperforms competitors on strong trading day - MarketWatch
Here's How Much $1000 Invested In Illumina 20 Years Ago Would Be Worth Today - Benzinga
Illumina stock holds near its yearly high as targets diverge - AD HOC NEWS
Illumina stock heads into the open after a 2.27 percent drop - AD HOC NEWS
Biotech ETFs to Buy as Cancer Drug Breakthroughs Accelerate - Zacks Investment Research
Illumina Inc. stock gains S&P 500 spot after strong earnings beats - AD HOC NEWS
Illumina, Inc. (ILMN) Stock Analysis: Navigating a Complex Landscape with High Growth Potential - DirectorsTalk Interviews
Illumina stock heads into the open after a 2.3 percent drop - AD HOC NEWS
Illumina, Inc.(NasdaqGS: ILMN) added to S&P 500 Equal Weighted - marketscreener.com
Illumina, Inc.(NasdaqGS: ILMN) added to S&P 500 Growth - marketscreener.com
Illumina, Inc.(NasdaqGS: ILMN) added to S&P 500 Health Care - marketscreener.com
Illumina, Inc.(NasdaqGS: ILMN) dropped from S&P 400 Health Care - marketscreener.com
Illumina stock gains as 2026 guidance rises - AD HOC NEWS
Illumina Stock Drops 2.3% Before Monday’s S&P 500 Return; Volume Jumps Ninefold - ts2.tech
Illumina Stock Is Up 133% This Year. Here’s Where It Could Go Further. - TIKR.com
Illumina Inc. stock gains on S&P 500 inclusion and strong 12-month rally - AD HOC NEWS
What Is Changing the Conversation Around Illumina (ILMN)? - kalkinemedia.com
Illumina Inc. stock underperforms Friday when compared to competitors - MarketWatch
Illumina Names Chief Commercial Officer and Chief Legal Officer - Medical Product Outsourcing
5 Green Days In A Row: Illumina Stock Is Up 22% - Trefis
Illumina Stock On Fire: Up 22% With 5-Day Winning Streak - Trefis
Illumina stock heads into the open after a 6.9% jump - AD HOC NEWS
Illumina, Inc.(NasdaqGS: ILMN) dropped from Russell Small Cap Comp Value Index - marketscreener.com
Illumina Inc Stock (ILMN) Closed Up by 7.10% on Sep 17: What Investors Need To Know - TradingKey
Illumina Inc. stock gains on S&P 500 inclusion and fresh 52-week high - AD HOC NEWS
Illumina stock reaches 52-week high at 231.82 USD - Investing.com
Illumina Inc (ILMN) Shares Surge 6.8% -- What GF Score of 71 Tel - GuruFocus
Illumina Jumps 5.2% Amid Sector-Wide Rally - AlphaStreet
Illumina Inc Stock (ILMN) Moved Up by 7.40% on Sep 15: Drivers Behind the Movement - TradingKey
Illumina Stock Climbs As Analyst Upgrades Meet S&P 500 Boost - StocksToTrade
Illumina (ILMN) Stock Draws Bullish Targets As S&P 500 Inclusion Nears - timothysykes.com
Illumina, Inc. (ILMN) Stock Analysis: Exploring Growth Potential Amidst A 32.34% ROE - DirectorsTalk Interviews
This Copart Analyst Turns Bullish; Here Are Top 2 Upgrades For Friday - Benzinga
Illumina Inc. stock gains support from UBS upgrade and raised 2026 outlook - ad-hoc-news.de
Illumina Inc. stock outperforms competitors despite losses on the day - MarketWatch
Illumina (NASDAQ: ILMN) CLO grants may pay up to 250% of target shares - Stock Titan
This Meta Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday - Benzinga
Advancing whole-genome sequencing with long-range data - News-Medical
Illumina stock heads into the open after a 2.1 percent slip - ad-hoc-news.de
Illumina CTO Steven Barnard Sells 408 Shares at $211.06 Each - Kalkine Media
Illumina Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Illumina (NASDAQ: ILMN) insider still holds 40,927 shares - Stock Titan
This Illumina Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday - Benzinga
Dear Illumina Stock Fans, Mark Your Calendars for September 21 - Barchart.com
UBS Upgrades Illumina to Buy From Neutral, Adjusts Price Target to $260 From $135 - marketscreener.com
3 Stocks Soon Joining the S&P 500 - TradingView
A Look at Illumina Inc (ILMN) After 3.3% Decline -- GF Value $13 - GuruFocus
Illumina Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Responsive Playbooks and the ILMN Inflection - Stock Traders Daily
Illumina Inc Azioni (ILMN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Illumina Inc Azioni (ILMN) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Meister Keith A. | Director |
Sep 03 '26 |
Sale |
218.23 |
75,951 |
16,574,481 |
889,851 |
| Meister Keith A. | Director |
Sep 02 '26 |
Sale |
213.28 |
68,108 |
14,526,254 |
965,802 |
0.10%
1.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):